SBI Securities’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.41K Buy
71
+61
+610% +$1.3K ﹤0.01% 2732
2026
Q2
$289 Sell
10
-126
-93% -$3.4K ﹤0.01% 3207
2026
Q1
$2.46K Buy
136
+134
+6,700% +$2.56K ﹤0.01% 2341
2025
Q4
$43 Hold
2
– – ﹤0.01% 3606
2025
Q3
$65 Hold
2
– – ﹤0.01% 3637
2025
Q2
$71 Hold
2
– – ﹤0.01% 3634
2025
Q1
$68 Hold
2
– – ﹤0.01% 3564
2024
Q4
$65 Buy
+2
New +$83 ﹤0.01% 3575

Other funds holding LEGN

SBI Securities's LEGN Position: Q3 2026 in Review

SBI Securities increased its Legend Biotech (LEGN) stake by 610% in Q3 2026, buying an estimated $1.3K and bringing the position to 71 shares worth $1.41K. The position accounts for ﹤0.01% of the portfolio, ranked #2732.

SBI Securities first reported a position in LEGN in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.46K in Q1 2026. 15 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.

  • SBI Securities held 71 shares of Legend Biotech worth $1.41K as of Q3 2026.
  • SBI Securities bought 61 Legend Biotech shares in Q3 2026, an estimated $1.3K.
  • Legend Biotech made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #2732 holding.
  • SBI Securities first reported a position in Legend Biotech in Q4 2024 and has held it in 8 quarters since.
  • SBI Securities's Legend Biotech position peaked at $2.46K in Q1 2026.
  • 15 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.